FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212833150> ?p ?o ?g. }

• W3212833150 endingPage "409" @default.
• W3212833150 startingPage "396" @default.
• W3212833150 abstract "Photothermal agents (PTAs) based on organic small-molecule dyes emerge as promising theranostic strategy in imaging and photothermal therapy (PTT). However, hydrophobicity, photodegradation, and low signal-to-noise ratio impede their transformation from bench to bedside. In this study, a novel supramolecular PTT formulation by a stimuli-responsive macrocyclic host is prepared to overcome these obstacles of organic small-molecule PTAs. Methods: Sulfonated azocalix[4]arene (SAC4A) was synthesized as a hypoxia-responsive macrocyclic host. Taking IR780 as an example, the supramolecular nanoformulation IR780@SAC4A was constructed by grinding method, and its solubility, photostability, and photothermal conversion were evaluated. The hypoxia tumor-selective imaging and supramolecular PTT of IR780@SAC4A were further evaluated in vitro and in vivo. Results: IR780@SAC4A is capable of enhancing the solubility, photostability, and photothermal conversion of IR780 significantly, which achieve this supramolecular formulation with good imaging-guided PTT efficacy in vitro and in vivo. Conclusions: This study demonstrates that the supramolecular PTT strategy is a promising cancer theranostic method. Moreover, this supramolecular approach is applicative to construct kinds of supramolecular PTAs, opening a general avenue for extending smart PTT formulations." @default.
• W3212833150 created "2021-11-22" @default.
• W3212833150 creator A5004997609 @default.
• W3212833150 creator A5012267050 @default.
• W3212833150 creator A5022217280 @default.
• W3212833150 creator A5047225525 @default.
• W3212833150 creator A5049860409 @default.
• W3212833150 creator A5052544950 @default.
• W3212833150 creator A5058049916 @default.
• W3212833150 creator A5070856900 @default.
• W3212833150 creator A5080749729 @default.
• W3212833150 creator A5091775788 @default.
• W3212833150 date "2022-01-01" @default.
• W3212833150 modified "2023-10-02" @default.
• W3212833150 title "A hypoxia-responsive supramolecular formulation for imaging-guided photothermal therapy" @default.
• W3212833150 cites W1996076368 @default.
• W3212833150 cites W1999733648 @default.
• W3212833150 cites W2006568020 @default.
• W3212833150 cites W2013089142 @default.
• W3212833150 cites W2032133327 @default.
• W3212833150 cites W2035938449 @default.
• W3212833150 cites W2063010667 @default.
• W3212833150 cites W2063242571 @default.
• W3212833150 cites W2074582913 @default.
• W3212833150 cites W2076521197 @default.
• W3212833150 cites W2082595868 @default.
• W3212833150 cites W2099940899 @default.
• W3212833150 cites W2110158220 @default.
• W3212833150 cites W2114763904 @default.
• W3212833150 cites W2117724887 @default.
• W3212833150 cites W2148677492 @default.
• W3212833150 cites W2331795519 @default.
• W3212833150 cites W2333059703 @default.
• W3212833150 cites W2468763661 @default.
• W3212833150 cites W2574211880 @default.
• W3212833150 cites W2590680367 @default.
• W3212833150 cites W2605407725 @default.
• W3212833150 cites W2607130122 @default.
• W3212833150 cites W2626839728 @default.
• W3212833150 cites W2725932575 @default.
• W3212833150 cites W2748417965 @default.
• W3212833150 cites W2753511090 @default.
• W3212833150 cites W2789925759 @default.
• W3212833150 cites W2793340380 @default.
• W3212833150 cites W2795134408 @default.
• W3212833150 cites W2802060594 @default.
• W3212833150 cites W2808179554 @default.
• W3212833150 cites W2883595277 @default.
• W3212833150 cites W2893450414 @default.
• W3212833150 cites W2899781070 @default.
• W3212833150 cites W2906405458 @default.
• W3212833150 cites W2911201489 @default.
• W3212833150 cites W2916168156 @default.
• W3212833150 cites W2947249369 @default.
• W3212833150 cites W2947304693 @default.
• W3212833150 cites W2947795134 @default.
• W3212833150 cites W2948998612 @default.
• W3212833150 cites W2956078842 @default.
• W3212833150 cites W2957408171 @default.
• W3212833150 cites W2971655587 @default.
• W3212833150 cites W2979261039 @default.
• W3212833150 cites W3002517292 @default.
• W3212833150 cites W3010811779 @default.
• W3212833150 cites W3012524279 @default.
• W3212833150 cites W3012649942 @default.
• W3212833150 cites W3017437165 @default.
• W3212833150 cites W3028868129 @default.
• W3212833150 cites W3039953362 @default.
• W3212833150 cites W3087981518 @default.
• W3212833150 cites W3096185915 @default.
• W3212833150 cites W3113565846 @default.
• W3212833150 cites W3119055052 @default.
• W3212833150 doi "https://doi.org/10.7150/thno.67036" @default.
• W3212833150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34987652" @default.
• W3212833150 hasPublicationYear "2022" @default.
• W3212833150 type Work @default.
• W3212833150 sameAs 3212833150 @default.
• W3212833150 citedByCount "24" @default.
• W3212833150 countsByYear W32128331502022 @default.
• W3212833150 countsByYear W32128331502023 @default.
• W3212833150 crossrefType "journal-article" @default.
• W3212833150 hasAuthorship W3212833150A5004997609 @default.
• W3212833150 hasAuthorship W3212833150A5012267050 @default.
• W3212833150 hasAuthorship W3212833150A5022217280 @default.
• W3212833150 hasAuthorship W3212833150A5047225525 @default.
• W3212833150 hasAuthorship W3212833150A5049860409 @default.
• W3212833150 hasAuthorship W3212833150A5052544950 @default.
• W3212833150 hasAuthorship W3212833150A5058049916 @default.
• W3212833150 hasAuthorship W3212833150A5070856900 @default.
• W3212833150 hasAuthorship W3212833150A5080749729 @default.
• W3212833150 hasAuthorship W3212833150A5091775788 @default.
• W3212833150 hasBestOaLocation W32128331501 @default.
• W3212833150 hasConcept C121608353 @default.
• W3212833150 hasConcept C126322002 @default.
• W3212833150 hasConcept C150903083 @default.
• W3212833150 hasConcept C171250308 @default.
• W3212833150 hasConcept C178790620 @default.
• W3212833150 hasConcept C182606246 @default.

• next